Ana María Gómez - Concepedia

Author

Ana María Gómez

Also Known As

A Gómez, A. M. Gómez, A. Macias Gómez, Ana Gómez, Ana M. Gómez, Ana Maria Quintero Gómez, Ana María Gómez, Astrid Batalla González, Gómez, Ana María, Gómez, Ana María Quintero

Publications

573

Citations

H-Index

Concepts

All Affiliations

Hospital Clínico San Carlos Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

About

Ana María Gómez is an author at Hospital Clínico San Carlos specializing in medicine, lung cancer, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	302
2	Health Sciences	2	2	80
3	Immunology	2	2	113
4	Biostatistics	1	1	26
5	Metabolism	1	1	26

Ana María Gómez

Publications

396

Citations

H-Index

Page 1

	Year	Citations
Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer Antonio Torres, ML Maestro, Ana María Gómez, British Journal of Cancer MedicineImmunologyPathologyCancer GenomicsBronchial Neoplasm	1996	69
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU David Vivas, Inmaculada Roldán, Raquel Ferrandis, Revista Española de Cardiología (English Edition) ThrombosisVenous DiseaseVenous ThrombosisConsensus DocumentAntithrombotic Therapy	2018	69
Clinical value of p53, c‐erbB‐2, CEA and CA125 regarding relapse, metastasis and death in resectable non‐small cell lung cancer Marina Pollán, Gonzálo Varela, Antonio Torres, International Journal of Cancer Surgical OncologyPrognosisPathologyClinical ValueOncology	2003	54
Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status Tamara Fernández‐Marcelo, Ana María Gómez, Irene Pascua, Journal of Experimental & Clinical Cancer Research	2015	48
A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer Susana Hernández-Prieto, Andrea Espiau Romera, Marı́a A. Ferrer, Clinical & Translational Oncology Cancer ImmunosurveillanceMedicineNovel Scoring SystemImmunologyPathology	2014	44
Regional citrate anticoagulation for continuous renal replacement therapy in children Mayerly Prada Rico, Jaime Fernández‐Sarmiento, Ana María Rojas Velásquez, Pediatric Nephrology ThrombosisPediatric HematologyKidney FailureChronic Kidney DiseaseHematology	2016	40
A Preliminary Analysis of Within-Subject Variation in Human Serum Oxidative Stress Parameters as a Function of Time Sandro Argüelles, Ana María Gómez, Alberto Machado, Rejuvenation Research NutritionDietary ExposureLipid PeroxidationLipid PeroxidesRedox Biology	2007	26
Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity Tamara Fernández‐Marcelo, Cristina Frías-López, Irene Pascua, Journal of Experimental & Clinical Cancer Research	2014	19
More than one pulmonary resections or combined lung‐liver resection in 79 patients with metastatic colorectal carcinoma J.R. Jarabo, Elena Fernández, Joaquín Calatayud, Journal of Surgical Oncology	2011	16
Profitability of our lung retrieval program from non heart beating donors☆ Elena Fernández, Joaquín Calatayud, J.R. Jarabo, European Journal of Cardio-Thoracic Surgery	2008	11

Page 1